| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 代理产品(元) | 18,175,012.83 | 64,165,610.06 | 23,638,698.66 | 58,200,120.50 | 32,870,236.89 |
| 第三方医学检验(元) | 30,518,382.20 | 65,754,419.06 | 49,001,490.84 | 297,957,457.53 | 198,071,121.32 |
| 体外诊断产品和解决方案(元) | 90,595,992.38 | 220,141,771.49 | 81,630,199.02 | 393,379,196.53 | 306,618,970.07 |
| 营业成本(元) | |||||
| 代理产品(元) | 13,600,999.31 | 47,238,783.18 | 16,867,999.12 | 37,326,611.79 | 21,622,841.56 |
| 第三方医学检验(元) | 3,491,011.77 | 7,858,617.10 | 4,200,404.09 | 120,324,846.61 | 85,473,126.16 |
| 体外诊断产品和解决方案(元) | 65,336,522.82 | 106,313,175.71 | 46,615,569.01 | 185,051,607.38 | 172,871,911.82 |
| 毛利(元) | |||||
| 代理产品(元) | 4,574,013.52 | 16,926,826.88 | 6,770,699.54 | 20,873,508.71 | 11,247,395.33 |
| 第三方医学检验(元) | 27,027,370.43 | 57,895,801.96 | 44,801,086.75 | 177,632,610.92 | 112,597,995.16 |
| 体外诊断产品和解决方案(元) | 25,259,469.56 | 113,828,595.78 | 35,014,630.01 | 208,327,589.15 | 133,747,058.25 |
| 毛利率(%) | |||||
| 代理产品(%) | 25.17 | 26.38 | 28.64 | 35.87 | 34.22 |
| 第三方医学检验(%) | 88.56 | 88.05 | 91.43 | 59.62 | 56.85 |
| 体外诊断产品和解决方案(%) | 27.88 | 51.71 | 42.89 | 52.96 | 43.62 |
| 收入构成(%) | |||||
| 代理产品(%) | 13.05 | 18.33 | 15.32 | 7.76 | 6.11 |
| 第三方医学检验(%) | 21.91 | 18.78 | 31.76 | 39.75 | 36.85 |
| 体外诊断产品和解决方案(%) | 65.04 | 62.89 | 52.91 | 52.48 | 57.04 |
| 毛利构成(%) | |||||
| 代理产品(%) | 8.04 | 8.97 | 7.82 | 5.13 | 4.37 |
| 第三方医学检验(%) | 47.53 | 30.69 | 51.74 | 43.66 | 43.71 |
| 体外诊断产品和解决方案(%) | 44.42 | 60.34 | 40.44 | 51.21 | 51.92 |